Glenmark Pharmaceuticals Ltd - Stock Price

As on3 Aug 2020
  • NSE : GLENMARK
  • BSE : 532296
  • ISIN CODE : INE935A01035
  • Industry : Pharmaceuticals & Drugs
  • House : Glenmark
Glenmark Pharmaceuticals Ltd is not traded on BSE/NSE
449.80
-0.56 %-2.55
Previous Close 452.35
Day's Open 455.40
Bid Price (Qty) 449.80 (3270)
Offer Price (Qty) 0.00 (0)
Day’s High - Low 461.90 - 448.00
52 Week Range 161.65 - 573.05
Volume Traded (in 000's) 4669.01
Value traded (in Cr.) 212.81
PE Ratio (x) 9.38
M Cap (in Cr.)12701.80

Glenmark Pharmaceuticals Ltd Stock Price

03/02/2017 | 15:19
  • Current Price8741.20
  • Open8735.15
  • High8748.25
  • Low8707.75
  • Prev. Close8734.25

Fundamentals

Parameter Values
Market Cap (Rs. in Cr.) 12701.80
Earning Per Share (EPS TTM) (Rs.) 48.01
Price To Earnings (P/E) Ratio 9.38
Book Value Per Share (Rs.) 468.74
Price/Book (MRQ) 0.96
Price/Earning (TTM) 8.51
ROCE (%) 15.78
PAT Margin 23.14
Dividend Yield 0.56
Face Value 1

Financial Summary

Parameter MAR 19 (`Mn.) MAR 18 (`Mn.) YoY %Change
Balance Sheet :
Share Capital282.17282.170.00
Total Non-Current Liabilities22799.3928241.18-19.27
Total Current Liabilities40210.9432878.9322.30
Total Liabilities119058.40112751.185.59
Total Non-Current Assets52090.1542864.2621.52
Currents Investments0.000.000.00
Cash and Bank9377.6512346.91-24.05
Total Current Assets66968.2569886.92-4.18
Total Assets119058.40112751.185.59
Profit & Loss :
Gross Sales98655.0091031.008.38
Net Sales98655.0090744.008.72
Total Expenditure82797.0074590.0011.00
Operating Profit17939.0017068.005.10
Profit After Tax9250.008039.0015.06
More from Financial Summary »

held by Mutual Fund Schemes

More from Held By MF Schemes »

News & Updates

  • There is no news in this stock

Share Holdings

Description Percent of Share (%)
Promoters46.62
Non-Institution24.44
Fi/Banks/Insurance3.16
Mutual Funds/Uti2.36
Government0
FII0
More from Share holdings »

Corporate Information

Management Info

  • Chairman: Glenn Saldanha
  • Managing Director: Glenn Saldanha
  • Secretary: Harish Kuber

Registered Office

Address : B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, Mumbai,
Maharashtra-400026
Tel : Fax : Email : webmaster@glenmarkpharma.com Website : www.glenmarkpharma.com

Registars Details

K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd. was incorporated in the year 1977. Its today's share price is 452.2. Its current market capitalisation stands at Rs 12701.8 Cr. In the latest quarter, company has reported Gross Sales of Rs. 70091.65 Cr and Total Income of Rs.74847.79 Cr. The company's management includes Saira Ramasastry, D R Mehta, Milind Sarwate, Julio F Ribeiro, B E Saldanha, Sridhar Gorthi, Bernard Munos, Brian W Tempest, Rajesh V Desai, VS Mani, Cherylann Pinto, Glenn Saldanha, Glenn Saldanha.

It is listed on the BSE with a BSE Code of 532296 , NSE with an NSE Symbol of GLENMARK and ISIN of INE935A01035. It's Registered office is at B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, Mumbai-400026, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Arthur Andersen & Associates, Price Waterhouse, VK Bahri & Co, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP

Latest News

close